Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4465719 | 0.96 | CCR5 (1.00) | CCR5KCNH2 | |
| Trifluoroacetic Acid SCHEMBL6008476 | 0.90 | CCR5 (0.74) | CCR5KCNH2 | |
| SCHEMBL4461045 | 0.89 | CCR5 (1.00) | CCR5KCNH2 | |
| SCHEMBL6005874 | 0.88 | CCR5 (0.80) | CCR5KCNH2 | |
| SCHEMBL6007035 | 0.87 | CCR5 (0.84) | CCR5KCNH2 | |
| Trifluoroacetic Acid SCHEMBL6005196 | 0.87 | CCR5 (0.70) | CCR5KCNH2 | |
| SCHEMBL6007543 | 0.87 | CCR5 (0.83) | CCR5KCNH2 | |
| Trifluoroacetic Acid SCHEMBL6005915 | 0.86 | CCR5 (0.74) | CCR5KCNH2 | |
| SCHEMBL6008113 | 0.85 | CCR5 (0.78) | CCR5KCNH2 | |
| SCHEMBL6007680 | 0.85 | CCR5 (0.80) | CCR5KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050176703-A1 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC | 2005-08-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176703-A1 | Heterocyclic antiviral compounds | CCR5, CCR3, CCR1 | CCR5 1/4885KCNH2 3129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.